HCA HEALTHCARE ($HCA) is expected to release its quarterly earnings data on Friday, July 25th before market open, per Finnhub. Analysts are expecting revenue of $18,679,975,138 and earnings of $6.31 per share.
You can see Quiver Quantitative's $HCA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HCA HEALTHCARE Insider Trading Activity
HCA HEALTHCARE insiders have traded $HCA stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $HCA stock by insiders over the last 6 months:
- JON M FOSTER (EVP and COO) sold 15,698 shares for an estimated $5,797,660
- JENNIFER BERRES (SVP & Chief Human Res. Officer) has made 0 purchases and 2 sales selling 9,533 shares for an estimated $3,075,240.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HCA HEALTHCARE Hedge Fund Activity
We have seen 538 institutional investors add shares of HCA HEALTHCARE stock to their portfolio, and 581 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ROYAL BANK OF CANADA removed 2,664,359 shares (-66.1%) from their portfolio in Q1 2025, for an estimated $920,669,252
- GAMMA INVESTING LLC removed 1,700,665 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $651,524,761
- PACER ADVISORS, INC. added 1,329,618 shares (+6237.9%) to their portfolio in Q1 2025, for an estimated $459,449,499
- WELLINGTON MANAGEMENT GROUP LLP removed 1,219,908 shares (-18.9%) from their portfolio in Q1 2025, for an estimated $421,539,209
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,091,416 shares (+83.4%) to their portfolio in Q1 2025, for an estimated $377,138,798
- BANK OF AMERICA CORP /DE/ added 1,044,748 shares (+46.7%) to their portfolio in Q1 2025, for an estimated $361,012,671
- QUBE RESEARCH & TECHNOLOGIES LTD removed 979,584 shares (-94.7%) from their portfolio in Q1 2025, for an estimated $338,495,251
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HCA HEALTHCARE Congressional Stock Trading
Members of Congress have traded $HCA stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $HCA stock by members of Congress over the last 6 months:
- REPRESENTATIVE JARED MOSKOWITZ has traded it 2 times. They made 2 purchases worth up to $30,000 on 05/15 and 0 sales.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/07.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 02/25.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
HCA HEALTHCARE Analyst Ratings
Wall Street analysts have issued reports on $HCA in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 07/16/2025
- RBC Capital issued a "Outperform" rating on 06/23/2025
- Barclays issued a "Overweight" rating on 06/02/2025
- B of A Securities issued a "Buy" rating on 05/13/2025
- Cantor Fitzgerald issued a "Overweight" rating on 01/27/2025
To track analyst ratings and price targets for HCA HEALTHCARE, check out Quiver Quantitative's $HCA forecast page.
HCA HEALTHCARE Price Targets
Multiple analysts have issued price targets for $HCA recently. We have seen 8 analysts offer price targets for $HCA in the last 6 months, with a median target of $407.5.
Here are some recent targets:
- Kevin Fischbeck from B of A Securities set a target price of $410.0 on 07/16/2025
- David Macdonald from Truist Securities set a target price of $415.0 on 07/16/2025
- Ben Hendrix from RBC Capital set a target price of $404.0 on 06/23/2025
- Craig Hettenbach from Morgan Stanley set a target price of $410.0 on 06/09/2025
- Andrew Mok from Barclays set a target price of $416.0 on 06/02/2025
- Stephen Baxter from Wells Fargo set a target price of $385.0 on 05/29/2025
- Michael Ha from Baird set a target price of $336.0 on 04/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
